| Narjis Seyyed Kazmi, MD | |
|
2799 W Grand Blvd # 417, Mc 426, Detroit, MI 48202-2608 | |
| (313) 916-8144 | |
| (313) 916-8144 |
| Full Name | Narjis Seyyed Kazmi |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2799 W Grand Blvd # 417, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588638621 | NPI | - | NPPES |
| 4665300 | Medicaid | MI | |
| 4665329 | Medicaid | MI | |
| 110D111790 | Other | MI | BCBSM |
| 4665276 | Medicaid | MI | |
| P00189990 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 4301076793 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | 4301076793 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Narjis Seyyed Kazmi, MD 2799 W Grand Blvd # 417, Detroit, MI 48202-2608 Ph: (313) 916-8144 | Narjis Seyyed Kazmi, MD 2799 W Grand Blvd # 417, Mc 426, Detroit, MI 48202-2608 Ph: (313) 916-8144 |
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.
For their annual conference, "Tipping Point? When Minority Families Become the Majority," the Council on Contemporary Families has collected some of the most important—though often under-reported—new findings about diversity in American family life.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced total revenue of $73.6 million for the quarter ended June 30, 2015 compared to $70.1 million for the quarter ended June 30, 2014.
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.
The U.S. Food and Drug Administration (FDA) has reached a settlement with California hearing device manufacturer Advanced Bionics LLC and its president and CEO Jeffrey Greiner over alleged violations of federal law
› Verified 5 days ago
Dr. Saba Alan Francis, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 50 E Canfield St, Detroit, MI 48201 Phone: 313-745-4525 | |
Dr. Roopkiranjot Kahlon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4201 Saint Antoine St, University Health Center 2e, Detroit, MI 48201 Phone: 313-745-4525 | |
Avi Cohen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Waleed Obaid, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3250 | |
Lindsey Aurora, Internal Medicine Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Alexander Garbarino, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Maria Diab, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 Fax: 313-876-1305 |